These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 11106307)

  • 21. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.
    Rietjens SJ; Hondebrink L; Westerink RH; Meulenbelt J
    Crit Rev Toxicol; 2012 Nov; 42(10):854-76. PubMed ID: 23030234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of "Ecstasy" blocked by serotonin reuptake inhibitors.
    Stein DJ; Rink J
    J Clin Psychiatry; 1999 Jul; 60(7):485. PubMed ID: 10453804
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmacokinetic and pharmacodynamic effects of methylphenidate and MDMA administered alone or in combination.
    Hysek CM; Simmler LD; Schillinger N; Meyer N; Schmid Y; Donzelli M; Grouzmann E; Liechti ME
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):371-81. PubMed ID: 24103254
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of 3,4-methylenedioxymethamphetamine (MDMA) and its main metabolites on cardiovascular function in conscious rats.
    Schindler CW; Thorndike EB; Blough BE; Tella SR; Goldberg SR; Baumann MH
    Br J Pharmacol; 2014 Jan; 171(1):83-91. PubMed ID: 24328722
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology.
    Dumont GJ; Kramers C; Sweep FC; Willemsen JJ; Touw DJ; Schoemaker RC; van Gerven JM; Buitelaar JK; Verkes RJ
    J Psychopharmacol; 2010 Feb; 24(2):165-74. PubMed ID: 19074534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteers.
    Vollenweider FX; Gamma A; Liechti M; Huber T
    Neuropsychopharmacology; 1998 Oct; 19(4):241-51. PubMed ID: 9718588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Physiological and subjective responses to controlled oral 3,4-methylenedioxymethamphetamine administration.
    Kolbrich EA; Goodwin RS; Gorelick DA; Hayes RJ; Stein EA; Huestis MA
    J Clin Psychopharmacol; 2008 Aug; 28(4):432-40. PubMed ID: 18626271
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Pharmacology of Mephedrone in Comparison with MDMA.
    Papaseit E; Pérez-Mañá C; Mateus JA; Pujadas M; Fonseca F; Torrens M; Olesti E; de la Torre R; Farré M
    Neuropsychopharmacology; 2016 Oct; 41(11):2704-13. PubMed ID: 27206266
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans.
    Freedman RR; Johanson CE; Tancer ME
    Psychopharmacology (Berl); 2005 Dec; 183(2):248-56. PubMed ID: 16163516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evidence that MDMA ('ecstasy') increases cannabinoid CB2 receptor expression in microglial cells: role in the neuroinflammatory response in rat brain.
    Torres E; Gutierrez-Lopez MD; Borcel E; Peraile I; Mayado A; O'Shea E; Colado MI
    J Neurochem; 2010 Apr; 113(1):67-78. PubMed ID: 20067581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Paroxetine inhibits acute effects of 3,4-methylenedioxymethamphetamine on the immune system in humans.
    Pacifici R; Pichini S; Zuccaro P; Farré M; Segura M; Ortuño J; Di Carlo S; Bacosi A; Roset PN; Segura J; de la Torre R
    J Pharmacol Exp Ther; 2004 Apr; 309(1):285-92. PubMed ID: 14722327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 3,4-Methylenedioxymethamphetamine (MDMA) as a unique model of serotonin receptor function and serotonin-dopamine interactions.
    Bankson MG; Cunningham KA
    J Pharmacol Exp Ther; 2001 Jun; 297(3):846-52. PubMed ID: 11356903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart.
    Peiró AM; Farré M; Roset PN; Carbó M; Pujadas M; Torrens M; Camí J; de la Torre R
    Psychopharmacology (Berl); 2013 Feb; 225(4):883-93. PubMed ID: 23142957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. α₁-Adrenergic receptors contribute to the acute effects of 3,4-methylenedioxymethamphetamine in humans.
    Hysek CM; Fink AE; Simmler LD; Donzelli M; Grouzmann E; Liechti ME
    J Clin Psychopharmacol; 2013 Oct; 33(5):658-66. PubMed ID: 23857311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacology of MDMA in humans.
    de la Torre R ; Farré M; Roset PN; Lopez CH; Mas M; Ortuño J; Menoyo E; Pizarro N; Segura J; Cami J
    Ann N Y Acad Sci; 2000 Sep; 914():225-37. PubMed ID: 11085324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice.
    Renoir T; Païzanis E; El Yacoubi M; Saurini F; Hanoun N; Melfort M; Lesch KP; Hamon M; Lanfumey L
    Int J Neuropsychopharmacol; 2008 Dec; 11(8):1149-62. PubMed ID: 18611291
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task.
    Vollenweider FX; Liechti ME; Paulus MP
    J Psychopharmacol; 2005 Jul; 19(4):366-74. PubMed ID: 15982991
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"): the influence of gender and genetics (CYP2D6, COMT, 5-HTT).
    Pardo-Lozano R; Farré M; Yubero-Lahoz S; O'Mathúna B; Torrens M; Mustata C; Pérez-Mañá C; Langohr K; Cuyàs E; Carbó Ml; de la Torre R
    PLoS One; 2012; 7(10):e47599. PubMed ID: 23112822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of MDMA and Intranasal oxytocin on social and emotional processing.
    Kirkpatrick MG; Lee R; Wardle MC; Jacob S; de Wit H
    Neuropsychopharmacology; 2014 Jun; 39(7):1654-63. PubMed ID: 24448644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.